Your browser doesn't support javascript.
loading
EphA2 antagonism alleviates LPS-induced acute lung injury via Nrf2/HO-1, TLR4/MyD88 and RhoA/ROCK pathways.
Feng, Guang; Sun, Bo; Liu, Hai-Xia; Liu, Qing-Hai; Zhao, Lei; Wang, Tian-Long.
Affiliation
  • Feng G; Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing 100053, PR China.
  • Sun B; Department of Anesthesiology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, PR China.
  • Liu HX; Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing 100053, PR China.
  • Liu QH; Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing 100053, PR China.
  • Zhao L; Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing 100053, PR China.
  • Wang TL; Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing 100053, PR China. Electronic address: w_tl5595@hotmail.com.
Int Immunopharmacol ; 72: 176-185, 2019 Jul.
Article in En | MEDLINE | ID: mdl-30986645
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Receptor, EphA2 / Acute Lung Injury / Antibodies, Monoclonal Limits: Animals / Humans / Male Language: En Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Receptor, EphA2 / Acute Lung Injury / Antibodies, Monoclonal Limits: Animals / Humans / Male Language: En Year: 2019 Type: Article